Nosis Bio
PrivateLast Round
Grant
Jul 18, 2023
Total Funding Raised
$13M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Nosis Bio operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Grant round in July 2023.
Nosis Bio is a biotechnology company that develops a drug delivery platform using artificial intelligence to create cell-targeted RNA medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nosis Bio Comparables
Compare Nosis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gensaic | 84% | |
| Mana.bio | 84% | |
| Bonito Biosciences | 83% |
For institutional investors. Book with your work email.
Nosis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 18, 2023 | ||||
| Seed | Mar 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nosis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Seed |
| Cystic Fibrosis Foundation | Seed, Grant |
| Madrona Venture Group | Seed |
| Sahsen Ventures | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 14, 58% of headcount.
- Aug 28, 2026
Grew 26% QoQ, from 19 to 24 employees.
For institutional investors. Book with your work email.
Nosis Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nosis Bio's valuation, stock price, and market status.
Is Nosis Bio a public or private company?
Nosis Bio is a private company.
What is the current stock price of Nosis Bio?
Nosis Bio is a private company, so its shares have no public market price. Caplight tracks Nosis Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nosis Bio worth (valuation)?
Valuation information for Nosis Bio is not publicly available.
Can I buy Nosis Bio stock?
Nosis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nosis Bio's last funding round?
Nosis Bio's most recent funding round was Grant on July 18, 2023.
Who are the main investors in Nosis Bio?
Key investors in Nosis Bio include AlleyCorp, Cystic Fibrosis Foundation, Madrona Venture Group, Sahsen Ventures, KdT Ventures.
Will Nosis Bio IPO soon?
No public IPO plans have been announced for Nosis Bio.
How can I track Nosis Bio secondary market activity?
Caplight tracks bids, offers, and trades in Nosis Bio's shares on secondary markets.